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Introduction
The growth of sessile forms of bacteria on various
surfaces has been described since the early 1900s. The term
“biofilm” has been used since 1975 and is defined as a
community of microbes that inhabit various surfaces and
are typically surrounded by extracellular matrices (ECMs).
Pseudomonas aeruginosa is an opportunistic pathogen and is
a huge threat to human health owing to its adaptation to
various environments and resistance against multiple
classes of antibiotics. P. aeruginosa is also known to develop
robust biofilms. P. aeruginosa biofilms have distinct
developmental stages. The initial attachment of P. aeruginosa
is mediated by adhesins, type IV pili, Psl, and
lipopolysaccharides, and is regulated by c-di-GMP and
small regulatory RNA (sRNA). Biofilm maturation is
characterized by the formation of biofilm structures and
ECM production. The detachment stage consists of sloughing,
erosion, and seeding dispersal, where sloughing and
erosion are passive detachments, and seeding dispersal is
an active detachment. The development of P. aeruginosa
biofilms is regulated by several factors, and one of the major
regulatory mechanisms is the quorum sensing (QS) system.
Biofilms have become a major issue in the medical field
because biofilm infections present high resistance to
antibiotics and the host immune response. Bacteria from
biofilms are also a major cause of chronic infections.
Biofilm research has been mostly limited to monospecies
biofilms, although biofilms rarely exist as monospecies in
natural environments. Interspecies interaction is known to
affect many genetic and phenotypic traits in multispecies
biofilms. Thus, it is important to study multispecies
biofilms to understand biofilms better. 
Brief History of Biofilm Research
Microbiology has evolved dramatically since Robert
Koch introduced Koch’s postulates and methods of
isolation and pure culture of a bacterium. These techniques
have been used in laboratories all over the world and have
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A biofilm is a community of microbes that typically inhabit on surfaces and are encased in an
extracellular matrix. Biofilms display very dissimilar characteristics to their planktonic
counterparts. Biofilms are ubiquitous in the environment and influence our lives
tremendously in both positive and negative ways. Pseudomonas aeruginosa is a bacterium
known to produce robust biofilms. P. aeruginosa biofilms cause severe problems in
immunocompromised patients, including those with cystic fibrosis or wound infection.
Moreover, the unique biofilm properties further complicate the eradication of the biofilm
infection, leading to the development of chronic infections. In this review, we discuss the
history of biofilm research and general characteristics of bacterial biofilms. Then, distinct
features pertaining to each stage of P. aeruginosa biofilm development are highlighted.
Furthermore, infections caused by biofilms on their own or in association with other bacterial
species (i.e., multispecies biofilms) are discussed in detail. 
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produced numerous studies for the diagnosis and
management of many devastating infectious diseases, such
as tuberculosis, cholera, and diphtheria. Because of these
important contributions of planktonic pure culture techniques
in the health of the human race, these techniques are
essential and have been the gold standard for the study of
microbes for several decades. However, microbiologists
still have continuously faced difficulties in eradicating
bacterial infections completely or growing many bacteria in
single-species planktonic cultures. 
Microbiologists started to realize that it was inadequate
to study bacteria in pure planktonic culture in order to
understand their natural lifestyle and interactions. The
differences between single-species planktonic cultured
bacteria and the same bacteria in sessile and mixed-species
cultures have been characterized owing to the development
of microscopy technologies. Most bacteria have completely
different phenotypes and physiological characteristics
when grown in pure planktonic conditions compared with
mixed-species sessile conditions. 
Since the early 1900s, many descriptions of sessile
cultures were made for surface-associated bacteria, marine
bacteria attachment on glass surfaces, and many others [1,
2]. The term biofilm had been unofficially used among
scientists, but the first official introduction of the term was
in the Microbial Ecology journal in 1975 [3]. Moreover, the
ubiquitous characteristics of biofilms were proposed in the
first quantitative examination of bacteria in specific
ecosystems by J. W. Costerton and his colleagues in 1978
[4]. They discovered an extensively large number of
bacteria in the biofilms from the surfaces of rocks from
alpine lakes and streams in Montana, but found a very
small number of planktonic bacteria, and the data were
confirmed in different locations [4]. Based on their data,
they confirmed that biofilms are a major form of bacterial
existence in nature, and the universality of biofilms was
suggested and confirmed not only in environmental
systems, but also in the industrial and medical fields [5].
Early in biofilm research, there was a limitation in
biofilm observation due to deformation and dehydration
during the preparation of samples for bright field or
electron microscopy. Thus, biofilms were thought to be a
uniform layer of bacteria that were covered in slime.
However, in the late 20th century, biofilm observation
using confocal laser scanning microscopy produced a
breakthrough in biofilm research through the discovery of
Fig. 1. Diagrammatic representation of the developmental stages of P. aeruginosa biofilm. 
The diagram presents (1) the planktonic stage, (2) attachment of bacteria to a surface, (3) production of the extracellular matrix, (4) maturation of
biofilm structures, (5) spatial differentiation, and (6) biofilm dispersal. 
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defined structures in biofilms, such as vertical structural
elements and water channels (Fig. 1) [6]. The discovery of a
complex biofilm architecture and the presence of water
channels in biofilm structures drew the attention of
microbiologists because it indicated that biofilms are not
just a collection of bacteria but are an actively developed
microbial community. The second breakthrough in biofilm
research was the discovery of differential gene expression
in biofilm bacteria compared with their planktonic
counterparts, which indicated refined regulatory systems
for biofilm development, and QS systems were revealed to
be one of the regulatory systems for biofilm development
[7, 8]. After these discoveries, research on biofilms increased
exponentially and became a new trend in microbiology. 
What Is a Biofilm? 
Biofilms are generally known as communities of microbes
that are attached to certain surfaces that are normally
covered with an ECM, secreted by the same microbes. The
components of the ECM are exopolysaccharide (EPS),
extracellular DNA (eDNA), RNA, proteins, and lipids [6, 9,
10]. The ECMs protect biofilms from harsh environments;
as such, bacteria in biofilms are generally more resistant to
various disinfectants and antimicrobial substances than
their planktonic counterparts [11, 12]. This resistant property
contributes to numerous biofilm-caused problems. In the
industrial field, biofilms cause malfunction of machines,
corrosion of facilities, blockage of pipelines, contamination
in drinking-water distribution systems, and safety issues in
the food industry [13, 14]. Because of the problems caused
by biofilms, an astronomical amount of money is being
spent every year to manage biofilms in these industries.
Furthermore, resistance to the host immune response can
lead to chronic infections in the host, which threatens many
lives worldwide [11]. 
However, biofilms are not always bad, and are positively
used in many applications. For example, biofilms are an
essential part of the bioremediation process. Bioremediation
bioreactors contain biofilms that degrade many toxic
contaminants and hazardous materials that are generated
from various industrial processes [15-17].
Pseudomonas aeruginosa
Pseudomonas species are ubiquitous in the natural
environment and cause disease in both animals and plants.
Among the Pseudomonas species, P. aeruginosa is the most
well-known pathogen that causes human infections.
P. aeruginosa is a gram-negative bacillus and is known as an
opportunistic pathogen. Although the bacterium only
causes mild infections, such as otitis media or otitis externa
in healthy individuals, it can also cause serious infections
in many different parts of the human body when the
immune system is compromised. For example, P. aeruginosa
is a major cause of mortality in cystic fibrosis (CF) patients.
In addition, P. aeruginosa causes bacteremic pneumonia,
endocarditis, meningitis, burn wound infections, and sepsis,
and these infections are associated with high mortality [17,
18]. P. aeruginosa is known to produce various virulence
factors, including flagella [19], type IV pili [20], alkaline
protease [21], elastase [22], lipopolysaccharide [23],
phospholipase [24], exotoxin A [25], pyoverdine [26],
pyochelin [26], pyocyanin [23], Pseudomonas quinolone
signal (PQS) [27], and more. P. aeruginosa has been studied
extensively; although many characteristics of this species
have been revealed, there are still many aspects of its exact
pathogenesis that remain undetermined [17, 28]. 
P. aeruginosa infection control is facing major challenges
owing to the constant emergence of antibiotic-resistant
strains. The escalated antibiotic resistance increases the rate
of disease occurrence and the mortality due to P. aeruginosa
infection. P. aeruginosa is the most common causative agent
of hospital-associated infection (HAI) and the second most
common cause of ventilator-associated pneumonia in the
USA [29]. The P. aeruginosa genome is relatively larger than
that of other prokaryotes, and P. aeruginosa has an
exceptionally large number of regulatory genes in its
chromosome, which contributes to the adaptation of this
species to various environmental conditions and is closely
related to the development of antibiotic resistance [10, 30].
Because of its ability to form biofilms, P. aeruginosa has
become the major cause of HAI. The conversion from the
planktonic to the biofilm stage changes the gene expression
pattern and increases the lateral gene transfer rate on a
large scale. These changes are known to contribute to
antibiotic resistance enhancement [31-33].
P. aeruginosa Biofilm Development 
Biofilm development models have changed several times
with the advancement of biofilm research techniques.
Advanced experimental techniques revealed that biofilm
development consists of three defined stages: initial
attachment, maturation, and detachment of the biofilm
(Fig. 1).
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Attachment of P. aeruginosa Biofilms
Many early studies on the initial attachment of bacteria
suggested the involvement of simple chemical bonds such
as Van der Waals forces. However, early-stage biofilm
development is composed of much more complex events
(Fig. 1). For example, there are a variety of bacterial structures
such as adhesins, type IV pili, and lipopolysaccharide
(LPS) that are involved in attachment, and these bacterial
structures are specifically regulated by environmental cues
[9, 34]. Recent studies demonstrated that the initiation of
biofilm formation occurs with an increase in c-di-GMP, an
intracellular second messenger [35-39]. Many types of
environmental cues can cause an increase in c-di-GMP,
which activates the production of adhesins and various
ECM products [35, 39]. For example, the contact of P.
aeruginosa to a surface is recognized by the WspA protein, a
membrane-bound receptor protein, which creates a signal
to produce c-di-GMP and in turn positively regulates the
production of CdrA adhesin, Psl, Pel, and alginate in
P. aeruginosa [40, 41]. Biofilm formation is also regulated by
sRNAs in many bacterial species [42], as Psl and Pel
production and the motile-to-sessile switch of P. aeruginosa
are regulated by sRNA [43, 44].
Maturation of P. aeruginosa Biofilms
After bacteria attach to surfaces or each other, they
undergo a series of changes to adapt to the new mode of
life. As surface-attached P. aeruginosa grow and form
microcolonies, they start to produce ECMs and build
structures and water channels (Fig. 1). As the biofilm
matures, the bacteria undergo physiological changes and
become much more resistant to stresses from the
environment or antibiotics. This biofilm development and
maturation are closely related to a signaling system called
quorum sensing [9, 10, 12]. 
Detachment of P. aeruginosa Biofilms
The final stage of biofilm development is detachment
(Fig. 1). There are several types of biofilm detachment
mechanisms: sloughing, erosion, and seed dispersal [34, 45,
46]. These detachment mechanisms are essential to create
new biofilms in new niches. The sloughing and erosion
mechanisms of biofilm detachment are called passive
detachments and are mediated by shear stress [34, 45].
Sloughing is the detachment of a large portion of a biofilm
from the original mass, and erosion is a washout of a small
portion of biomass or bacteria from the outer surface [45].
Seed dispersal is the active detachment mechanism of
P. aeruginosa biofilms. In this process, P. aeruginosa biofilms
release single planktonic cells or microcolonies from the
center of the biofilm, leaving an empty cavity [45].
Dispersal of biofilms is closely related to microcolony size.
Dispersal starts with spatial differentiation, which is
described as the differential localization of motile and non-
motile P. aeruginosa in the biofilm structure when the
biofilm reaches a critical size [45, 46]. The motile bacteria
locate in the mushroom cavity, and the non-motile bacteria
locate at the stalk and walls of the mushroom structure
(Fig. 1) [45, 46]. This dispersal mechanism involves ECM
degradation and autolysis of a biofilm subpopulation.
Biofilm dispersion can also be induced by environmental
cues, such as nutrients, oxygen availability, nitric oxide
(NO), pH, and various chemicals. For example, a sudden
increase in glucose supply can decrease intracellular c-di-
GMP, which increases flagella production and induces
dispersal [41]. Moreover, limited oxygen supply can induce
biofilm dispersal by enhancing c-di-GMP degradation [46].
NO stimulates phosphodiesterase activity, which decreases
the intracellular c-di-GMP level in P. aeruginosa and leads
to dispersal of the biofilm [46]. In addition, there are
various chemicals that contribute to the dispersal of
P. aeruginosa biofilms, such as metal chelators, cis-2-
decenoic acid, anthranilate, and other surfactants [47-49].
Important Characteristics of P. aeruginosa Biofilm
Extracellular Matrix of P. aeruginosa Biofilms 
ECMs of biofilms usually consist of EPS, eDNA, and
proteins, which act as a matrix, adhesive material, and
protective barrier [10, 11]. There are three identified EPSs
in P. aeruginosa: Psl, Pel, and alginate [50]. Psl polysaccharide
was named for the polysaccharide synthesis locus that was
identified in 2004 [51, 52]. Psl is an important component of
the ECM for initiation and maintenance of P. aeruginosa
biofilms by providing cell-surface attachment and
intercellular interactions. In the late stage of biofilm
maturation, Psl was shown to accumulate on the outside of
structured biofilms [53, 54]. This Psl accumulation provides
structural support and allows for later dispersion of the
P. aeruginosa biofilm. Psl can also physically interact with
eDNA to form a web of eDNA-Psl. The eDNA-Psl web
structure provides structural support of the biofilm.
Furthermore, the eDNA-Psl interaction could increase the
survival of P. aeruginosa in vivo by utilizing neutrophil
extracellular traps as a biofilm scaffold [55].
Pel polysaccharide is an essential component for
P. aeruginosa to form pellicles at the air-liquid interface and
solid surface-associated biofilms [52, 56]. The other roles of
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Pel are to act as a platform for biofilm structure and to
provide protection against aminoglycoside antibiotics [54,
57]. However, most of these roles depend on the strains of
P. aeruginosa. The complete biochemical composition of Pel
has not yet been identified. So far, Pel is known to be
composed of cationic amino sugars, which facilitate
binding with eDNA of the biofilm [58, 59]. Pel can also
compensate for Psl when there is a lack of Psl production in
the biofilm periphery [58]. As mentioned, one of the
mechanisms for Psl and Pel production is through the c-di-
GMP signaling pathway owing to environmental cues, and
another postulated Pel production mechanism is involved
in the association of LPS. For example, the pel operon is
involved in maintaining the association of 3-deoxy-D-
manno-octulosonic acid (Kdo) sugar, a core oligosaccharide
of LPS, to the bacterial cells [38-41].
Alginate is the most studied EPS of P. aeruginosa biofilms,
and is mainly produced by P. aeruginosa strains isolated
from CF patients [54]. Alginate is known as a factor used to
distinguish mucoid or non-mucoid P. aeruginosa biofilms,
although it was found that Psl also contributes to the
mucoid phenotype of the biofilms [60]. Alginate plays many
important roles for biofilms. For example, alginate retains
water and nutrients, and provides antibiotic resistance and
immune evasion [61-63].
Another component of the ECM is eDNA. There are
several hypotheses regarding the production of eDNA in
biofilms, such as active secretion, autolysis of bacteria, and
release from small membrane vesicles [53, 64]. eDNA is
known to play roles in the formation of cation gradients,
antibiotic resistance, nutrient source, and early biofilm
development [53, 65-67]. Moreover, eDNA is a major
proinflammatory factor for P. aeruginosa biofilms [68]. 
Other than EPS and eDNA, proteins also contribute to
formation of the biofilm matrix [53]. For example, flagella
act as an adhesin to help initial bacterial attachment to the
surface [69]. Type IV pili contribute to the formation of
mushroom-like biofilm cap structures [69, 70]. CdrA adhesin
interacts with Psl and increases biofilm stability [10, 41].
Cup fimbriae are also one of the proteinaceous components
of the ECM and play important roles in cell-to-cell interaction
during the initial stage of biofilm formation [10, 71].
Quorum Sensing in P. aeruginosa Biofilms
QS is an intercellular communication system that enables
bacteria to sense their own population density [72]. QS
systems rely on small signaling molecules; N-acyl-homoserine
lactones for gram-negative bacteria, oligopeptides for
gram-positive bacteria, and autoinducer-2 (AI-2) for both
classes of bacteria [72, 73]. QS systems not only sense
population density, but also regulate a variety of traits,
such as bacterial phenotype, spatial differentiation in
biofilms, motility, and biofilm formation [74]. Genetic
expression analysis also revealed that several hundred
genes in P. aeruginosa are regulated by QS systems [75, 76].
There are four types of QS systems in P. aeruginosa;
namely, las, rhl, PQS, and integrated QS (IQS) (Fig. 2). The
las, rhl, and PQS systems have been extensively studied,
and IQS was recently added to the P. aeruginosa QS system.
The las QS system is involved in the production of N-3-oxo-
dodecanoyl homoserine lactones (N-3-C12-HSL) by the
signal synthase LasI, and sensing the signal by the receptor
LasR, which activates transcription of target genes [77]. In
the rhl QS system, RhlI of P. aeruginosa is involved in the
synthesis of N-butanoyl-L-homoserine lactone (C4-HSL),
and RhlR, the signal receptor, induces the target gene
expression when C4-HSL binds to it [8, 77]. The role of QS
systems in biofilm formation was reported first in 1998 by
Davis and his colleagues in P. aeruginosa biofilms [74]. They
demonstrated that a lasI mutant of P. aeruginosa only forms
flat and undifferentiated biofilms, and the rhlI gene is
known to be involved in the formation of a mushroom cap
structure in P. aeruginosa biofilms and in the dispersal of
biofilms by controlling the production of rhamnolipids [72,
78] (Fig. 2). Besides the biofilm formation, the las and rhl QS
systems regulate numerous gene expressions, such as
production of elastase, protease, rhamnolipids, and other
virulence factors (Fig. 2). Another QS system of P. aeruginosa
is the PQS system that senses 2-heptyl-3-hydroxy-4-
quinolone (PQS) [72, 79]. The operon, pqsABCDE, is
encoded for the synthesis of 2-heptyl-4-quinolone (HHQ), a
precursor of PQS, and 2-alkyl-4-quinolone, and PqsH
converts the HHQ to PQS. The PQS is recognized by the
cognate receptor PqsR, and regulates PQS production [80].
The PQS system regulates eDNA release in biofilm
formation and membrane vesicle production (Fig. 2) [27,
79, 81]. PQS influences many other metabolic processes in
P. aeruginosa, such as iron chelation, redox homeostais,
elastase production, rhamnolipid production, membrane
vesicle formation, and so on [27, 76, 82]. The importance of
PQS in multispecies interaction has been discovered. For
example, PQS inhibits the biofilm formation of Streptococcus
mutans by inhibiting the attachment of S. mutans to the
surface [83]. Other microorganisms can also affect the PQS
regulation, such as farnesol from Candida albicans that can
inhibit PQS synthesis by antagonizing the activity of PqsR
[84]. 
The last QS system that had been discovered recently is
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IQS, which can integrate environmental stress cues into
the QS. The QS molecule of the IQS system is 2-(2-
hydroxyphenyl)-thiazole-4-carbaldehyde (C
10
H
7
O
2
NS) [85].
The operon that encodes for IQS synthesis is ambBCDE. IQS
regulates the production of PQS and C4-HSL, as well as of
related virulence factors, such as elastase, rhamnolipids,
and pyocyanin. IQS is regulated by las and the phosphate
stress response regulator PhoB. Phosphate stress is a
common stress when the bacteria infect hosts, and thus this
stress activates the IQS system and results in the increase of
bacterial virulence [76, 85]. These QS systems have hierarchial
relationships among them. The las system possesses the
highest position in the QS system where it regulates the rhl,
PQS, and IQS systems [77, 86]. The rhl system is at the
lowest level, regulated by all the other QS systems, and
activates the many QS-related virulence factors. PQS is
activated by las and IQS, and activates the rhl system. IQS
is activated by las and regulates the PQS and rhl systems
(Fig. 2) [76]. However, each QS system can also be activated
by environmental factors, such as phosphate stress [87],
starvation [88], low oxygen [77], low iron [89], and several
host-derived factors [76, 85].
P. aeruginosa Biofilm Infections 
Biofilms have become a major issue in the medical field
because biofilm infections present high resistance not only
to antibiotics, but also to the host immune response [19, 21,
29]. In addition, microbial pathogen biofilms are major
causes of chronic infection [11]. Biofilm-associated infections
can be divided into two categories. First are biofilm
infections due to indwelling medical devices. For example,
there are infections associated with central venous catheters,
urinary catheters, prosthetic joints, peritoneal dialysis
catheters, pacemakers, contact lenses, and intrauterine
devices. The second are direct biofilm infections in host
tissues, such as chronic pneumonia in CF patients, chronic
otitis media, endocarditis, chronic osteomyelitis, chronic
prostatitis, palindromic urinary tract infection, and gingivitis
[90]. The major problem with biofilm infections in diverse
medical settings is due to their outstanding resistance
against various antibiotics and other disinfectants. The
microbes in biofilms can be hundreds of times more
resistant than their planktonic counterparts [62]. To obtain
high antibiotic resistance, microbes in biofilms use several
Fig. 2. Interactions between quorum sensing systems of P. aeruginosa. 
Blue arrows represent an activation effect. The blue perpendicular line represents an inhibitory effect. Black arrows represent virulence factor
outputs (black box) and functions in biofilm development (blue box).
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biofilm-specific mechanisms, and these mechanisms are
different than those commonly used by planktonic microbes.
One of the biofilm-specific antibiotic-resistant mechanisms
is the physical barrier provided by the ECM that retards
the distribution of antibiotics into the biofilm. The
distribution rate varies among the types of antibiotics and
microorganisms in the biofilm [62, 91]. Biofilms also possess
a sub-population called persister cells. The persister cells
proliferate extremely slowly or stop growth altogether.
This metabolic arrest could act as a resistance mechanism
against strong external stress such as antibiotics [31].
Furthermore, if bacteria develop biofilms due to the
starvation-induced stress response, the cells in the inner
part of the biofilm are restricted with regard to oxygen and
nutrient supply, which leads to the inhibition of growth
and increase of amino acid synthesis for survival. This
starvation-induced stringent response plays an important
role in enhancing biofilm resistance [92]. Furthermore,
glucan production and efflux pumps are known as antibiotic
resistance mechanisms in biofilms. Ethanol oxidation,
eDNA, and iron acquisition are thought to contribute to
antibiotic resistance with mechanisms that are still unknown
[62, 93-96].
P. aeruginosa can use the mechanisms mentioned above
to infect and inhabit various sites of the human body.
P. aeruginosa is notorious for causing pneumonia in the CF
patient lung, and it is a primary cause of death of CF
patients [97]. The P. aeruginosa biofilms in the CF lung
consist of small aggregates encased in EPS. The biofilms
induce inflammation of the infected lung by recruiting
polymorphonuclear leukocytes [17, 18]. The biofilm can
make the bacteria survive through the inflammation and
aggressive antibiotic treatment, and cause persistent
infection. The chronic inflammatory response against the
infection causes tissue damage and eventually leads to
lung failure [98].
Another P. aeruginosa biofilm infection is otitis media, an
infection in the middle ear. It is very common among
children and can cause serious inflammation that may lead
to conductive hearing loss [99]. The biofilm consists of
small microcolonies that contain less than a hundred
bacteria. P. aeruginosa also cause chronic bacterial prostatitis,
a bacterial infection of the prostate gland. It is a major
cause of relapsed urinary tract infections in men. The
microcolonies of P. aeruginosa are associated with the
ductal wall of the prostate duct and cause the disease [98,
100]. One of the major problems of P. aeruginosa biofilm
infection is chronic wound infection. Chronic wounds are
normally associated with vascular abnormalities such as
decubitus ulcers, ischemic injuries, diabetic foot ulcers, and
venous leg ulcers [99, 100]. These chronic wounds create
suitable environments for bacteria to colonize since the
skin barriers are compromised. The microbial infections in
chronic wounds are multispecies infections, consisted of
both aerobic and anaerobic bacteria. Among the isolated
bacteria from the chronic wounds, P. aeruginosa and
Staphylococcus aureus are the most common [101, 102].
P. aeruginosa exists in biofilms in the wounds, and locates
in a deeper part of the wounds than S. aureus. Furthermore,
chronic wounds with P. aeruginosa infection tend to be
larger, more inflamed, and slower to recover [99, 101]. It
could be due to the characteristics of the P. aeruginosa
biofilm, such as type IV pili and flagella-mediated motility,
and production of virulence factors that protect the
bacteria from the host defense systems [98]. 
Another very important P. aeruginosa biofilm infection is
those on medically implanted devices. P. aeruginosa is
frequently isolated from infections on urinary catheters,
intravascular catheters, artificial joints, and cochlear
implants [96, 98]. Biofilms have been isolated from almost
all medical device-related infections and are very difficult
to remove. These infections are at a high risk of progression
to systemic infections. The only treatment of biofilm
infections on medical devices so far is the removal of the
device.
P. aeruginosa in Multispecies Biofilms 
In the last three decades, there have been remarkable
transitions in microbiology research from the study of pure
planktonic cultures to that of biofilms, which is one step
closer to the natural form of microbial living. However,
much of biofilm research is still investigating pure single-
species biofilms, even though pure-species biofilms do not
mimic real world microbial biofilms. Multispecies biofilms
are the major form in the environment and in the human
host. Metagenomic analysis of the human microbiome
revealed that there are thousands of bacterial species that
reside in the human gastrointestinal tract, oral cavity,
respiratory tract, skin, and vaginal tract [103]. Even though
most species remain unculturable, they exist and interact
with each other. Therefore, it is important to investigate
multispecies biofilms and the microbial interactions that
affect biofilm development and host health. 
The interspecies interactions within biofilms involve QS
systems, metabolic cooperation, or competition, and these
interactions result in synergistic or antagonistic effects on
the biofilms. Several studies demonstrated that interactions
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in a polymicrobial biofilm affect the overall characteristics
that enhance resistance or virulence [103-105]. For
example, microbes in dental plaque undergo spatiotemporal
interactions and alter the surroundings in order to promote
pathogenic bacterial species to colonize and survive [106].
Staphylococcus aureus has been shown to increase infectivity
and biofilm development when interacting with C. albicans
in serum [105]. 
Among the QS systems, the autoinducer-2 (AI-2) system
was identified in both gram-negative and gram-positive
bacteria and is utilized in interspecies interactions [107,
108]. For instance, an increase in the level of AI-2
concentration induces polymicrobial biofilm formation of
Streptococcus oralis and Acinetobacter naeslundii [109]. Another
recently identified QS signal that influences interspecies
interactions is the diffusible signal factor (DSF), a fatty acid
signal [110]. DSF, secreted by Stenotrophomonas maltophilia,
enhances polymyxin resistance and biofilm formation of
P. aeruginosa [111]. In addition to the examples above, there
are many complex interspecies interactions that influence
antibiotic resistance, ECM production, or growth [103, 104,
112]. 
There have been several studies of P. aeruginosa in
multispecies biofilms. Ghadakpour et al. [113] demonstrated
that P. aeruginosa can successfully integrate and proliferate
in multispecies biofilms, and they even showed that
P. aeruginosa can utilize the multispecies biofilms as niches.
Interspecies and interkingdom interactions between
P. aeruginosa and other microorganisms are important for
either microorganism to survive in the environments. For
example, interactions between P. aeruginosa and C. albicans
in a biofilm increase the synthesis of QS molecules,
virulence factor production, and mutability to survive from
host defense mechanisms [114]. P. aeruginosa and S. aureus
are the major pathogens isolated from the lungs of CF
patients. The interactions between P. aeruginosa and
S. aureus promote biofilm formation in the flow condition.
S. aureus releases eDNA for P. aeruginosa to form biofilms,
and P. aeruginosa facilitates the microcolony formation of
S. aureus [115]. In addition, P. aeruginosa protects S. aureus
from phagocytic protozoa when they are co-cultured in
biofilms [115]. Moreover, Mashburn et al. [116] showed that
the transcription of iron-regulated genes of P. aeruginosa
decreased when S. aureus was co-cultured in vivo. They
suggested that S. aureus could be used as a source of iron for
P. aeruginosa under iron-limiting condition. According to
their investigation, S. aureus grows faster than P. aeruginosa
during early iron-limited condition, and then P. aeruginosa
lyses the S. aureus by a PQS-mediated mechanism, which
releases intracellular iron from S. aureus [116]. P. aeruginosa
and S. aureus are frequently isolated from wound infections.
Pastar et al. [101] demonstrated that the interaction of these
two bacteria in the dual-species biofilm has a synergistic
effect on the wound healing process, which is the
significant delay of re-epithelialization by suppression of
keratinocyte growth factor 1. P. aeruginosa also interacts
with a common fungal respiratory pathogen, Aspergillus
fumigatus, in the biofilm, and produces more elastase [117].
Thus, CF patients infected with both P. aeruginosa and
A. fumigatus may display a poorer prognosis. The study of
polymicrobial urinary tract infection with P. aeruginosa and
Enterococcus faecalis revealed that E. faecalis aggravates
pyelonephritis, caused by P. aeruginosa, which significantly
curtailed the time to onset of the disease [118]. As shown
above, all the multispecies biofilm infections with
P. aeruginosa displayed increased virulence. However, studies
of the multispecies biofilm are very limited owing to
difficulties in experimental techniques. Therefore, it is
important to develop new and easier experimental settings
to study multispecies biofilms. 
In conclusion, the pure planktonic culture method of
microbiology had been the major and only method used to
study microbiology for a long time. However, microbiologists
realized the pure planktonic culture method does not
represent the natural ecosystem, and it alters the actual
physiology of the microorganisms. Thus, the concept of the
biofilm emerged as a model to investigate more relevant
bacterial lifestyles. Since then, the study of biofilms has
rapidly advanced. This research has provided important
physiological and molecular information about biofilm
development and characteristics. Even though we have a
better understanding of biofilms, there are still many
limitations in the removal of biofilms from natural
environments, industrial sites, or chronic infections. Research
on multispecies biofilms and their interspecies interactions
is essential to better understand biofilms. However, it is
uncertain whether the knowledge and techniques for
monospecies biofilm research are appropriate for the study
of multispecies biofilms. Several new investigation tools
have been introduced in genomics, proteomics, and
microscopy for biofilm investigations, but much more
research is needed in order to find optimal methods to
study multispecies biofilms. 
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